QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ABSI

QT62Absci Corporation
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
7.41
+0.23+3.20%
OverviewShort InterestFilings
ABSIQT62Absci Corporation·NASDAQ
OverviewShort InterestFilings
7.41+3.20%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-0.94
Insider Own-
Shs Outstand-
Perf Week13.82%
Market Cap1.12BForward P/E-EPS next Y-0.72Insider Trans-Shs Float-Perf Month60.04%
Enterprise Value1.12BPEG-EPS next Q-0.16Inst Own-Short Float-Perf Quarter140.58%
Income-120671094.00P/S609.69EPS this Y18.19%Inst Trans-Short Ratio-Perf Half Y108.73%
Sales1.84MP/B6.39EPS next Y6.70%ROA-60.55%Short Interest-Perf YTD112.32%
Book/sh-P/C-EPS next 5Y-ROE-63.58%52W High8.17 -9.30%Perf Year173.43%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-72.28%52W Low2.24 230.80%Perf 3Y-
Dividend Est.-EV/EBITDA-10.44Sales past 3/5Y-20.63% -9.71%Gross Margin-1316.88%Volatility8.34% 7.53%Perf 5Y-
Dividend TTM-EV/Sales607.40EPS Y/Y TTM8.51%Oper. Margin-7000.82%ATR (14)0.69Perf 10Y-
Dividend Ex-Date-Quick Ratio6.59Sales Y/Y TTM0.00%Profit Margin-6450.76%RSI (14)63.71Recom2.00
Dividend Gr. 3/5Y-Current Ratio6.59EPS Q/Q9.52%SMA2015.84%Beta3.20Target Price10.03
Payout0.00%Debt/Eq0.03Sales Q/Q-100.00%SMA5040.20%Rel Volume1.67Prev Close7.18
Employees156LT Debt/Eq0.02EarningsAug 11SMA20099.88%Avg Volume5.05MPrice7.41
IPO DateJul 22, 2021Option/ShortYes / YesEPS/Sales Surpr.5.00% -100.00%Net Debt/EBITDA0.04Volume8,435,307Change3.20%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-15-26ReiteratedGuggenheimBuy$15
Jun-04-26InitiatedLeerinkOutperform$12
May-28-26InitiatedBTIGBuy$9.00
May-14-26ReiteratedMorgan StanleyOverweight$4.20 → $4.10
Jan-08-26ReiteratedMorgan StanleyOverweight$4.32
Dec-17-25ReiteratedH.C. Wainwright$7.00 → $8.00
Mar-21-24ReiteratedStifel Nicolaus$6.00
Aug-12-22DowngradeJP MorganOverweight → Underweight
Aug-12-22UpgradeCowen & Co.Market Perform → Outperform
Nov-10-21DowngradeB of A SecuritiesNeutral → Underperform
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue535
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A561262
Gross Profit-53-9-58
Selling, General and Administrative Excl. Other9350
Research and Development728164
Other Operating Expense-160-13
Operating Income-118-125-109
Interest Expense001
Unusual Expense
———
Non-Operating Income (Expense)-5-10-1
Net Income Before Taxes-112-115-103
Income Taxes000
Consolidated Net Income-113-115-103
Net Income From Continuing Operations-113-115-103
Net Income-113-115-103
EPS (Recurring)-0.94-0.84-0.94
EPS (Basic, Before Extraordinaries)-0.94-0.84-0.94
EPS (Diluted)-0.94-0.84-0.94
EBITDA-99-103-94
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio189.70159.38—
Gross Margin-1,060.00-300.00-1,160.00
Operating Margin-2,360.00-4,166.67-2,180.00
Net Margin-2,260.00-3,833.33-2,060.00
Shares Outstanding128137110
Market Capitalization948478—
Operating Lease Expense
———
Insider Trading Volume
$8.66$8.04$7.41$6.79$6.17● Close Price0.00K70.45K140.89K211.34K281.79KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Pangalos Menelas NDirectorMay 13 '26Buy5.3637,453200,748232,308May 13 12:00 AM
Busch AndreasChief Innovation OfficerMar 12 '26Buy2.29100,000229,000421,446Mar 16 12:00 AM
Pangalos Menelas NDirectorFeb 27 '26Buy2.7475,095205,760189,055Mar 03 12:00 AM
McClain SeanChief Executive OfficerFeb 23 '26Option Exercise1.21792,798959,2868,730,966Feb 25 12:00 AM
McClain SeanChief Executive OfficerFeb 02 '26Sale2.9926,76180,0158,334,567Feb 04 12:00 AM
Jonasson ZachariahCFO / CBOFeb 02 '26Sale2.9917,49652,313383,538Feb 04 12:00 AM
VAN HOUTEN FRANSDirectorDec 05 '25Buy3.7240,000148,80063,320Dec 09 12:00 AM
Pangalos Menelas NDirectorSep 22 '25Buy2.6695,785254,788113,960Sep 24 12:00 AM
Bedrick ToddSVP, CAOSep 22 '25Buy2.7010,00027,000180,428Sep 24 12:00 AM
Busch AndreasChief Innovation OfficerJul 28 '25Buy3.0450,000152,000327,264Jul 29 12:00 AM
Jonasson ZachariahCFO / CBOJun 13 '24Sale4.9819,85998,892384,751Jun 14 12:00 AM
Jonasson ZachariahCFO / CBOJun 13 '24Option Exercise3.3957,400194,586404,610Jun 14 12:00 AM
Phoenix Venture Partners II LP10% OwnerMay 22 '24Sale4.403,100,00013,640,00011,279,522May 28 12:00 AM
Redmile Group, LLCDirectorMar 01 '24Buy4.50222,222999,9998,253,316Mar 05 12:00 AM
SCHIFFMAN GREGORY TChief Financial OfficerOct 20 '22Option Exercise0.55100,00055,000605,165Oct 24 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR